Ambiq Micro, Inc. 8-K

What Happened
Ambiq Micro, Inc. announced that effective January 5, 2026 it increased its Board of Directors from six to seven members and appointed Dr. Bernard B. Banks to the newly created directorship. Dr. Banks will serve as a Class III director until the Company’s 2028 annual meeting of stockholders, when he is expected to stand for election. The Board also appointed him as a member of the Audit Committee.

Key Details

• Board size increased from six to seven directors; appointment effective January 5, 2026.
• Dr. Bernard B. Banks will serve as a Class III director through the 2028 annual meeting.
• Dr. Banks was appointed to the Audit Committee.
• Background: Director of Rice University’s Doerr Institute for New Leaders; former senior leader/faculty at Northwestern Kellogg; retired U.S. Army Brigadier General with 29 years’ service; holds a Ph.D. in social-organizational psychology from Columbia University and multiple advanced degrees (MBA Northwestern, MPA Harvard, among others).
• Compensation and indemnification: He will be paid under the Company’s Non‑Employee Director Compensation Policy and has entered into the Company’s standard director indemnification agreement (as disclosed in the Company’s Amendment No. 1 to Form S-1 filed July 21, 2025).
• No family relationships, special arrangements, or related-party transactions reportable under Item 404(a) of Regulation S‑K.

Why It Matters
A new, independent director with audit committee membership can affect board oversight of financial reporting and corporate governance—areas investors watch for risk management and financial integrity. The filing notes standard compensation and indemnification and no related-party ties, which reduces immediate conflict-of-interest concerns.